The role of ghrelin, neuropeptide y and leptin peptides in weight gain after deep brain stimulation for Parkinson's disease

Stereotactic and Functional Neurosurgery

Volumn 90, Issue 2, 2012, Pages 104-112

  Markaki, Elli ^a   Ellul, John ^b   Kefalopoulou, Zinovia ^a   Trachani, Eftichia ^b   Theodoropoulou, Anastasia ^b   Kyriazopoulou, Venetsana ^b   Constantoyannis, Constantine ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Deep brain stimulation; Ghrelin; Hypothalamus; Leptin; Neuropeptide Y; Neuroprotection; Parkinson's disease; Weight

Indexed keywords

GHRELIN; LEPTIN; LEVODOPA; NEUROPEPTIDE Y;

ARTICLE; BLOOD LEVEL; BODY COMPOSITION; BRAIN DEPTH STIMULATION; DISEASE ASSOCIATION; HORMONE RELEASE; HYPOTHALAMUS; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; WEIGHT GAIN;

AGED; BODY COMPOSITION; DEEP BRAIN STIMULATION; FEMALE; GHRELIN; HUMANS; LEPTIN; MALE; MIDDLE AGED; NEUROPEPTIDE Y; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 84857733378     PISSN: 10116125     EISSN: 14230372     Source Type: Journal    
DOI: 10.1159/000335045     Document Type: Article

References (42)

1. Poewe W: Non motor symptoms in parkinson's disease; in Jankovic J, Tolosa E (eds): Parkinson's Disease and Movement Disorders, ed 5. Philadelphia, Lippincott Williams and Wilkins, 2007, pp 67-76.
2. Markus HS, Cox M, Tomkins AM: Raised resting energy expenditure in parkinson's disease and its relationship to muscle rigidity. Clin Sci (Lond) 1992; 83: 199-204.
3. Jankovic J, Wooten M, Van der Linden C, Jansson B: Low body weight in parkinson's disease. South Med J 1992; 85: 351-354.
4. Beyer PL, Palarino MY, Michalek D, Busenbark K, Koller WC: Weight change and body composition in patients with parkinson's disease. J Am Diet Assoc 1995; 95: 979-983.
5. Perlemoine C, Macia F, Tison F, Coman I, Guehl D, Burbaud P, Cuny E, Baillet L, Gin H, Rigalleau V: Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in parkinson's disease. Br J Nutr 2005; 93: 191-198.
6. Gironell A, Pascual-Sedano B, Otermin P, Kulisevsky J: Weight gain after functional surgery for parkinsons disease. Neurologia 2002; 17: 310-316. (Pubitemid 34847540)
7. Novakova L, Ruzicka E, Jech R, Serranova T, Dusek P, Urgosik D: Increase in body weight is a non-motor side effect of deep brain stimulation of the subthalamic nucleus in parkinson's disease. Neuro Endocrinol Lett 2007; 28: 21-25. (Pubitemid 46291142)
8. Montaurier C, Morio B, Bannier S, Derost P, Arnaud P, Brandolini-Bunlon M, Giraudet C, Boirie Y, Durif F: Mechanisms of body weight gain in patients with parkinson's disease after subthalamic stimulation. Brain 2007; 130: 1808-1818. (Pubitemid 47343807)
9. Macia F, Perlemoine C, Coman I, Guehl D, Burbaud P, Cuny E, Gin H, Rigalleau V, Tison F: Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight. Mov Disord 2004; 19: 206-212. (Pubitemid 38312705)
10. Barichella M, Marczewska AM, Mariani C, Landi A, Vairo A, Pezzoli G: Body weight gain rate in patients with parkinson's disease and deep brain stimulation. Mov Disord 2003; 18: 1337-1340. (Pubitemid 38263320)
11. Vardi J, Oberman Z, Rabey I, Streifler M, Ayalon D, Herzberg M: Weight loss in patients treated long-term with levodopa. Metabolic aspects. J Neurol Sci 1976; 30: 33-40.
12. Chen TY, Duh SL, Huang CC, Lin TB, Kuo DY: Evidence for the involvement of dopamine d(1) and d(2) receptors in mediating the decrease of food intake during repeated treatment with amphetamine. J Biomed Sci 2001; 8: 462-466.
13. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS: Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999; 20: 68-100. (Pubitemid 29092036)
14. Murphy KG, Dhillo WS, Bloom SR: Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev 2006; 27: 719-727. (Pubitemid 44936055)
15. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992.
16. Druce M, Bloom SR: The regulation of appetite. Arch Dis Child 2006; 91: 183-187. (Pubitemid 43362529)
17. Yamada T, Katagiri H: Avenues of communication between the brain and tissues/organs involved in energy homeostasis. Endocr J 2007; 54: 497-505. (Pubitemid 47414595)
18. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S: A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198. (Pubitemid 32144284)
19. Steiger A: Eating and sleeping -their relationship to ghrelin and leptin. Am J Physiol Regul Integr Comp Physiol 2004; 287:R1031-R1032. (Pubitemid 39391044)
20. Yildiz BO, Suchard MA, Wong ML, McCann SM, Licinio J: Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci USA 2004; 101: 10434-10439. (Pubitemid 38924943)
21. Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, Shimbara T, Guan JL, Wang QP, Funahashi H, Sakurai T, Shioda S, Matsukura S, Kangawa K, Nakazato M: Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 2003; 144: 1506-1512. (Pubitemid 36428493)
22. Valassi E, Scacchi M, Cavagnini F: Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 2008; 18: 158-168. (Pubitemid 351282471)
23. Gil-Campos M, Aguilera CM, Canete R, Gil A: Ghrelin: a hormone regulating food intake and energy homeostasis. Br J Nutr 2006; 96: 201-226. (Pubitemid 46476321)
24. Stanley S, Wynne K, McGowan B, Bloom S: Hormonal regulation of food intake. Physiol Rev 2005; 85: 1131-1158. (Pubitemid 41363743)
25. Escamilla-Sevilla F, Perez-Navarro MJ, Munoz-Pasadas M, Saez-Zea C, Jouma-Katati M, Piedrola-Maroto G, Ramirez-Navarro A, Minguez-Castellanos A: Change of the melanocortin system caused by bilateral subthalamic nucleus stimulation in parkinson's disease. Acta Neurol Scand 2011; 124: 275-281.
26. Bannier S, Montaurier C, Derost PP, Ulla M, Lemaire JJ, Boirie Y, Morio B, Durif F: Overweight after deep brain stimulation of the subthalamic nucleus in parkinson disease: long term follow-up. J Neurol Neurosurg Psychiatry 2009; 80: 484-488.
27. Lukaski HC: Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 1987; 46: 537-556. (Pubitemid 18005716)
28. Grosset K, Needleman F, Macphee G, Grosset D: Switching from ergot to nonergot dopamine agonists in parkinson's disease: a clinical series and five-drug dose conversion table. Mov Disord 2004; 19: 1370-1374. (Pubitemid 39534561)
29. Schaltenbrand G, Wahren A: Stereotaxic Atlas of the Human Brain. New York, Thieme Verlag, 1982.
30. Guimaraes J, Matos E, Rosas MJ, Vieira-Coelho A, Borges N, Correia F, Vaz R, Garrett C: Modulation of nutritional state in Parkinsonian patients with bilateral subthalamic nucleus stimulation. J Neurol 2009; 256: 2072-2078.
31. Abbott RA, Cox M, Markus H, Tomkins A: Diet, body size and micronutrient status in parkinson's disease. Eur J Clin Nutr 1992; 46: 879-884. (Pubitemid 23023500)
32. Bachmann CG, Trenkwalder C: Body weight in patients with parkinson's disease. Mov Disord 2006; 21: 1824-1830. (Pubitemid 44848926)
33. Nozaki S, Saito T, Matsumura T, Miyai I, Kang J: Relationship between weight loss and dysphagia in patients with parkinson's disease. Rinsho Shinkeigaku 1999; 39: 1010-1014. (Pubitemid 30022610)
34. McDonald WM, Richard IH, DeLong MR: Prevalence, etiology, and treatment of depression in parkinson's disease. Biol Psychiatry 2003; 54: 363-375. (Pubitemid 37267863)
35. Muller A, Mungersdorf M, Reichmann H, Strehle G, Hummel T: Olfactory function in parkinsonian syndromes. J Clin Neurosci 2002; 9: 521-524.
36. Markus HS, Tomkins AM, Stern GM: Increased prevalence of undernutrition in parkinson's disease and its relationship to clinical disease parameters. J Neural Transm Park Dis Dement Sect 1993; 5: 117-125. (Pubitemid 23177178)
37. Tuite PJ, Maxwell RE, Ikramuddin S, Kotz CM, Billington CJ, Laseski MA, Thielen SD: Weight and body mass index in parkinson's disease patients after deep brain stimulation surgery. Parkinsonism Relat Disord 2005; 11: 247-252. (Pubitemid 40692837)
38. Corcuff JB, Krim E, Tison F, Foubert-Sanier A, Guehl D, Burbaud P, Cuny E, Baillet L, Gin H, Rigalleau V, Perlemoine C: Subthalamic nucleus stimulation in patients with parkinson's disease does not increase serum ghrelin levels. Br J Nutr 2006; 95: 1028-1029. (Pubitemid 43805393)
39. Andrews ZB, Erion D, Beiler R, Liu ZW, Abizaid A, Zigman J, Elsworth JD, Savitt JM, Di-Marchi R, Tschoep M, Roth RH, Gao XB, Horvath TL: Ghrelin promotes and protects nigrostriatal dopamine function via a ucp2-dependent mitochondrial mechanism. J Neurosci 2009; 29: 14057-14065.
40. Jiang H, Li LJ, Wang J, Xie JX: Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp Neurol 2008; 212: 532-537.
41. Czermak C, Hauger R, Drevets WC, Luckenbaugh DA, Geraci M, Charney DS, Neumeister A: Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression. J Affect Disord 2008; 110: 277-281.
42. Moon J, Tobkin S, Smith A, Roberts M, Ryan E, Dalbo V, Lockwood C, Walter A, Cramer J, Beck T, Stout J: Percent body fat estimations in college men using field and laboratory methods: a three-compartment model approach. Dyn Med 2008; 7: 7.